Showing results (1-10 of 622) with videos related to
Sort By:
Pageof 63
Clinical Nephrology|April 1, 1988
Risk factors for the development of chronic cyclosporine-nephrotoxicityM J Mihatsch, K Steiner, K H Abeywickrama, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1995
The value of different resistance parameters in distinguishing biopsy-proved dysfunction of renal allograftsB Frauchiger, A Bock, R Eichlisberger, et al.Transplantation|July 1, 1992
The efficacy and tolerability of cyclosporine G in human kidney transplant recipientsB Huser, G Thiel, M Oberholzer, et al.Transplantation|March 27, 1995
A randomized prospective trial of prophylactic immunosuppression with ATG-fresenius versus OKT3 after renal transplantationH A Bock, H Gallati, R M Zürcher, et al.Ultrastructural Pathology|May 1, 1992
Giant mitochondria in "zero-hour" transplant biopsiesM J Mihatsch, V Basler, E Curschellas, et al.Clinical Nephrology|November 1, 1991
Morphologic findings in "zero-hour" biopsies of renal transplantsE Curschellas, J Landmann, M Dürig, et al.Toxicology Letters|March 1, 1989
Cyclosporin A: action and side-effectsM J Mihatsch, G Thiel, B RyffelThe British Journal of Dermatology|June 1, 1990
Renal side-effects of cyclosporin A with special reference to autoimmune diseasesM J Mihatsch, G Thiel, B RyffelTherapeutische Umschau. Revue Therapeutique|February 1, 1990
[Problems with long-term immunosuppression following organ transplantation]G Thiel, J Landmann, M MihatschClinical Nephrology|November 1, 1990
von Willebrand factor and factor VIII in renal transplant recipients under immunosuppression with cyclosporine and steroids. Sequential measurements over 4 months in 17 patientsB Huser, B Lämmle, J Landmann, et al.Pageof 63